{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-23-028651","form_type":"8-K","ticker":"CBUS","cik":"0001705843","company_name":"Cibus, Inc.","filed_at":"2023-08-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.927665+00:00","generated_at":"2026-06-11T22:42:40.848300+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Cibus Q2 2023 net loss $20.5M; reports business progress with trait transfers and Bayer collaboration","bullets":["Net loss of $20.5M ($3.05 per share) vs $2.5M loss in prior-year quarter; cash $50.9M expected into Q1 2024.","Closed merger of Cibus Global and Calyxt on May 31, 2023; first trait transfers to Nuseed (canola pod shatter) and Nutrien (rice HT1/HT3) completed.","Opened 32,000 sq ft Oberlin facility in San Diego for semi-automated high-throughput gene editing trait production.","Entered collaboration with Bayer Ag to evaluate Cibus' Trait Machine platform for precision gene editing.","EU regulation proposal would treat Cibus' gene-edited traits as 'conventional-like', opening EU market if adopted."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-23-028651","json":"https://secwatch.observer/filing/0001628280-23-028651.json","markdown":"https://secwatch.observer/filing/0001628280-23-028651.md","text":"https://secwatch.observer/filing/0001628280-23-028651.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1705843/000162828023028651/0001628280-23-028651-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1705843/000162828023028651/cbus-20230809.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T22:42:40.848300+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"cc2cd39bc98dc4f4be857278f42be16317cd4fdd","claim":"Cibus, Inc. reported financial results for three months ended June 30, 2023.","evidence_excerpt":"On August 9, 2023, Cibus, Inc. (the “Company”) announced its financial results for the three months ended June 30, 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1705843/000162828023028651/0001628280-23-028651-index.htm","confidence":0.7,"family_label":"Earnings Releases","details":[{"label":"Period","value":"three months ended June 30, 2023"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}